Henry J. Fuchs

2020

In 2020, Henry J. Fuchs earned a total compensation of $7.5M as President, Worldwide R&D at BioMarin Pharmaceutical, a 6% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$536,250
Option Awards$1,385,520
Salary$769,231
Stock Awards$4,732,826
Other$32,748
Total$7,456,575

Fuchs received $4.7M in stock awards, accounting for 63% of the total pay in 2020.

Fuchs also received $536.3K in non-equity incentive plan, $1.4M in option awards, $769.2K in salary and $32.7K in other compensation.

Rankings

In 2020, Henry J. Fuchs' compensation ranked 1,273rd out of 13,090 executives tracked by ExecPay. In other words, Fuchs earned more than 90.3% of executives.

ClassificationRankingPercentile
All
1,273
out of 13,090
90th
Division
Manufacturing
452
out of 5,620
92nd
Major group
Chemicals And Allied Products
156
out of 2,253
93rd
Industry group
Drugs
135
out of 1,953
93rd
Industry
Pharmaceutical Preparations
98
out of 1,458
93rd

Pay ratio

Henry J. Fuchs' Pay$7,456,575
Median Employee's Pay$181,141
Pay Ratio

41

to 1

In 2020, the annual total compensation of Henry J. Fuchs was $7,456,575.

The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.

The ratio of Henry J. Fuchs' pay to the pay of median employee was therefore 41 to one.

Source: SEC filing on April 13, 2021.

Fuchs' colleagues

We found six more compensation records of executives who worked with Henry J. Fuchs at BioMarin Pharmaceutical in 2020.

2020

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

2020

C Guyer

BioMarin Pharmaceutical

Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations

2020

Brian Mueller

BioMarin Pharmaceutical

Chief Financial Officer

2020

Robert Baffi

BioMarin Pharmaceutical

Former President of Global Manufacturing and Technical Operations

2020

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

2020

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

News

You may also like